Beauty Health Company Class A (SKIN)

Over the past six months, The Beauty Health Co.'s stock (SKIN) has experienced volatility. In November 2025, the company reported Third Quarter 2025 Financial Results and appointed Philippe Schaison to its Board of Directors. In December 2025, BeautyHealth released its Third Annual Skintuition Report. In March 2026, the company reported Full Year and Fourth Quarter 2025 Financial Results, with Q4 revenue beating forecasts but declining year-over-year, while EPS missed estimates, and adjusted EBITDA surged year-over-year. The company also announced the expansion of its skin health ecosystem with the growing adoption of SkinStylus Nano-Channeling. The company projected Q1 2026 revenue of $63 million to $68 million and positive adjusted EBITDA of $3.5 million to $5.5 million, noting that the first quarter is historically its lowest revenue quarter due to seasonal dynamics.

Demand for The Beauty Health Co.'s products and services, particularly HydraFacial treatments, exhibits seasonality, with the first quarter historically being the lowest revenue quarter. HydraFacial treatments are positioned as a year-round solution, adaptable to different seasonal skin needs, addressing concerns related to summer, fall, winter, and spring. A notable surge in search interest for "hydrofacial machine" was observed towards the end of 2025, specifically in December.

The Beauty Health Co. (SKIN) is a medtech meets beauty company that designs, develops, manufactures, markets, and sells aesthetic technologies and products globally, operating within the Consumer Defensive sector, focusing on skin health experiences for all demographics. Its major product portfolio includes HydraFacial, which pioneered hydradermabrasion, SkinStylus, which specializes in microneedling, Keravive, which focuses on scalp health, and the MyBeautyHealth mobile app, which allows consumers to earn loyalty points and track skin concerns.

The Beauty Health Co. has a global presence, delivering solutions in the Americas, Asia-Pacific, Europe, the Middle East, Africa, Canada, and Latin America. HydraFacial treatments are available in over 90 countries, with a global installed base of over 35,000 devices as of June 2025. The company has expanded its direct market presence through acquisitions of distributors in key international markets such as Germany, Australia, France, and Mexico.

HydraFacial, the company's flagship brand, enjoys a strong reputation backed by industry-leading consumer trust and satisfaction. It ranks as the second most recognized facial treatment in the U.S. and boasts a 96% "Worth It" rating on RealSelf, along with an industry-leading 52 Net Promoter Score. Providers report that HydraFacial is a treatment clients specifically ask for by name. The brand's success is attributed to its science-based innovation and a portfolio of over 175 patents.

The ownership structure of The Beauty Health Co. (SKIN) is a mix of institutional, insider, and retail investors. Institutional owners hold approximately 33.89% to 41.60% of the company's stock, with major shareholders including Mirabella Financial Services Llp, Fmr Llc, and BlackRock, Inc. Insiders own approximately 14.47% to 57.62% of the stock, with Brent L. Saunders owning the most shares among individual investors. Retail investors hold approximately 43.93% of the stock.